Jeffrey Aubé

Jeffrey Aubé is affiliated with the Eshelman School of Pharmacy at the University of North Carolina, Chapel Hill, United States. Since 2007, he has been actively engaged in evaluating and recommending scientific publications, including Technical Advances and commentaries.

His research interests span Pharmaceutical Sciences, Medicinal Chemistry, Drug Discovery, Organic Synthesis, Pharmacology, and Computational Chemistry. These areas reflect his focus on advancing therapeutic strategies through molecular design and pharmacological analysis.

Jeffrey Aubé has contributed to the academic community by analyzing technical advances, such as those by Feng Q et al. (2023), Li R et al. (2021), and Glover SA (2019). His expertise in pharmaceutical research is further demonstrated through his ongoing recommendations and leadership in the field.